首页> 外文期刊>亚太热带医药杂志(英文版) >Seroprevalence of varicella zoster virus in Colombo district, Sri Lanka
【24h】

Seroprevalence of varicella zoster virus in Colombo district, Sri Lanka

机译:水痘带状疱疹病毒在斯里兰卡科伦坡区的血清阳性率

获取原文
获取原文并翻译 | 示例
       

摘要

Objective: To determine the seroprevalence of varicella zoster virus (VZV) antibodies among the population residing in the Colombo district of Sri Lanka. Methods: A cross-sectional population-based study was conducted which included 1 258 participants. Blood samples were collected and questionnaires administered to obtain sociodemographic information and history of varicella and/or herpes zoster. Serum samples were assayed for VZV IgG antibodies using a commercial enzyme-linked immunosorbent assay kit. Results: Overall, the seroprevalence was 54.2% (95% CI = 51.5% 57.0%). Children below 1 year of age were seronegative, and only about 20.0% of children between 1 and 10 years of age were seropositive. Seropositivitiy increased with age and by the age of 40 years 74.3% were seropositive. Among women of childbearing age, the overall seroprevalence was about 62.0% (95% CI = 57.7%-66.1%) but was low 37.0% in the 15-19 age group. Conclusion: In this population, 45.8% lacked natural immunity against varicella. Of women of childbearing age, 39.9% lacked immunity and in the subgroup of women 15-19 years of age, 63.0% women lacked immunity. In light of the country''s success with the control and high coverage of other vaccine preventable diseases and that the vaccine is available in the private sector, the inclusion of varicella vaccine in the national immunization program may be considered.
机译:目的:确定斯里兰卡科伦坡区居民中水痘带状疱疹病毒(VZV)抗体的血清阳性率。方法:进行了一项基于人群的横断面研究,其中包括1 258名参与者。收集血样并进行问卷调查,以获取社会人口统计学信息以及水痘和/或带状疱疹的病史。使用市售的酶联免疫吸附测定试剂盒对血清样品中的VZV IgG抗体进行测定。结果:总体上,血清阳性率为54.2%(95%CI = 51.5%57.0%)。 1岁以下的儿童具有血清反应阳性,而1至10岁的儿童中只有约20.0%呈血清反应阳性。血清阳性随年龄增加而增加,到40岁时血清阳性为74.3%。在育龄妇女中,总体血清阳性率约为62.0%(95%CI = 57.7%-66.1%),但在15-19岁年龄组中仅为37.0%。结论:该人群中有45.8%的人缺乏对水痘的天然免疫力。在育龄妇女中,有39.9%的妇女缺乏免疫力,而在15-19岁妇女的亚组中,有63.0%的妇女没有免疫力。鉴于该国在控制和高覆盖其他疫苗可预防疾病方面取得了成功,并且该疫苗可在私营部门获得,因此可以考虑将水痘疫苗纳入国家免疫规划。

著录项

  • 来源
    《亚太热带医药杂志(英文版)》 |2018年第001期|53-57|共5页
  • 作者单位

    Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, USA;

    Public Health Specialist/Medical Epidemiologist, Office-WHO Manila, Philippines;

    Department of Microbiology, University of Sri Jayawardenapura, Sri Lanka;

    Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, USA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-19 03:58:15
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号